EUVIMEDEUVIMED entdecken
Crossref

Serum anti‐Spike immunoglobulin G levels in random blood donors in Italy: High‐titre convalescent plasma is easier than ever to procure

Daniele Focosi, Silvia Meschi, Sabrina Coen, Maria Carla Iorio, Massimo Franchini iD, Maria Lanza, Fabrizio Maggi

Vox Sanguinis · 2023

DOI: 10.1111/vox.13498 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vox Sanguinis, 2023. Verfasst von Daniele Focosi und 6 weiteren Autor:innen. Beteiligte Einrichtung: North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy. Hauptthemen laut MEDLINE: COVID-19, Cancer Vaccines. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives COVID‐19 convalescent plasma (CCP) has retained potency and clinical efficacy against SARS‐CoV‐2 and is currently of utmost value for seronegative immunocompromised patients. Since most of the effect is due to the vaccine boost of infection‐elicited antibodies, there is a theoretical concern that the frequency of suitable donors is declining. Materials and Methods In this single‐institution serosurvey, we screened 599 consecutive donors attending our area in two different seasons (300 in November 2022 and 299 in February 2023) using the Abbott Alinity® anti‐Spike immunoglobulin G assay.

Results

More than 80% of random donors qualify according to the FDA criteria for high‐titre CCP (>4350 AU/mL), with a stable trend.

Conclusion

Despite reduced anti‐Spike vaccine boost deployment in the general population, we have shown here that high‐titre CCP units are easier than ever to procure. This finding also has implications for the derivation of standard immunoglobulins, which are finally approaching the potency of hyperimmune serum and could soon represent an alternative to CCP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Cancer VaccinesHumansBlood DonorsCOVID-19 SerotherapySARS-CoV-2ItalyImmunoglobulin GAntibodies, ViralImmunization, PassiveAntibodies, Neutralizing

Stichwörter der Autor:innen

COVID-19SARS-CoV-2blood donorsconvalescent plasma

Substanzen

Cancer VaccinesImmunoglobulin GAntibodies, ViralAntibodies, Neutralizing

Autor:innen und Institutionen

  • North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.
  • Laboratory of Virology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
  • Carlo Poma Hospital, Mantua, Italy.

ORCID-Profile: Massimo Franchini

Zitieren

APA

Focosi, D., Meschi, S., Coen, S., Iorio, M. C., Franchini, M., Lanza, M., & Maggi, F. (2023). Serum anti‐Spike immunoglobulin G levels in random blood donors in Italy: High‐titre convalescent plasma is easier than ever to procure. Vox Sanguinis. https://doi.org/10.1111/vox.13498

Vancouver

Focosi D, Meschi S, Coen S, Iorio MC, Franchini M, Lanza M, et al. Serum anti‐Spike immunoglobulin G levels in random blood donors in Italy: High‐titre convalescent plasma is easier than ever to procure. Vox Sanguinis. 2023. doi:10.1111/vox.13498

BibTeX
@article{Focosi2023,
  author = {Focosi, Daniele and Meschi, Silvia and Coen, Sabrina and Iorio, Maria Carla and Franchini, Massimo and Lanza, Maria and Maggi, Fabrizio},
  title = {Serum anti‐Spike immunoglobulin G levels in random blood donors in Italy: High‐titre convalescent plasma is easier than ever to procure},
  journal = {Vox Sanguinis},
  year = {2023},
  doi = {10.1111/vox.13498}
}
Kostenlos starten →